A Comprehensive Flow Cytometry Panel for Analysis of Idiopathic Subglottic Stenosis

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Raymond J. So, Samuel L. Collins, Yee Chan‐Li, Ioan Lina, Alexander Gelbard, Kevin M. Motz, Alexander T. Hillel
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867019370546331648
author Raymond J. So
Samuel L. Collins
Yee Chan‐Li
Ioan Lina
Alexander Gelbard
Kevin M. Motz
Alexander T. Hillel
author_facet Raymond J. So
Samuel L. Collins
Yee Chan‐Li
Ioan Lina
Alexander Gelbard
Kevin M. Motz
Alexander T. Hillel
Raymond J. So
Samuel L. Collins
Yee Chan‐Li
Ioan Lina
Alexander Gelbard
Kevin M. Motz
Alexander T. Hillel
collection Wiley Open Access
contents A Comprehensive Flow Cytometry Panel for Analysis of Idiopathic Subglottic Stenosis Raymond J. So Samuel L. Collins Yee Chan‐Li Ioan Lina Alexander Gelbard Kevin M. Motz Alexander T. Hillel Otolaryngology–Head and Neck Surgery AbstractObjectiveTo present a comprehensive flow cytometry panel for idiopathic subglottic stenosis (iSGS).Study DesignControlled ex vivo cohort study.SettingTertiary care academic hospital in a metropolitan area.MethodsFlow cytometry and single‐cell RNA sequencing were performed on 9 paired normal and scar tissue samples from iSGS patients. Flow cytometry was used to assess the presence of myeloid (CD11b, CD14, CD15, Siglec8), lymphoid (CD3, CD4, CD8, gamma delta [γδ], FOXP3), endothelial (CD31), fibroblast (CD90, SMA), and epithelial (CD326, CK5) markers.ResultsOn flow cytometry, iSGS scar is characterized by an increased presence of myeloid, lymphoid, endothelial, and fibroblast cell types, but a decreased presence of epithelial cells. In the myeloid lineage, iSGS scar samples demonstrated increased CD11b+ monocytes (P < .001), Siglec8+ eosinophils (P = .03), and CD14+ monocytes (P = .02). In the lymphoid lineage, iSGS scar demonstrated increased CD3+ T‐cells (P < .001), CD4+ helper T‐cells (P < .001), γδ+ T‐cells (P < .001), and FOXP3+ regulatory T‐cells (P = .002). iSGS scar exhibited specific increases in CD90+ (P = .04) and SMA+ (P < .001) fibroblasts but decreased CD326+ (E‐cadherin) epithelial cells (P = .01) relative to normal samples.ConclusionWe present a comprehensive flow cytometry panel for iSGS. This flow panel may serve as a common platform among airway scientists to elucidate the cellular mechanisms underpinning iSGS and other upper airway pathologies. Scar iSGS samples demonstrate a distinct cellular profile relative to normal iSGS specimens, exhibiting increased fibroblast, endothelial, and inflammatory cell types but decreased epithelium. 10.1002/ohn.754 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/ohn.754
format Artículo Open Access
id wiley_oa_10_1002_ohn_754
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle A Comprehensive Flow Cytometry Panel for Analysis of Idiopathic Subglottic Stenosis
Raymond J. So
Samuel L. Collins
Yee Chan‐Li
Ioan Lina
Alexander Gelbard
Kevin M. Motz
Alexander T. Hillel
Otolaryngology–Head and Neck Surgery
A Comprehensive Flow Cytometry Panel for Analysis of Idiopathic Subglottic Stenosis Raymond J. So Samuel L. Collins Yee Chan‐Li Ioan Lina Alexander Gelbard Kevin M. Motz Alexander T. Hillel Otolaryngology–Head and Neck Surgery AbstractObjectiveTo present a comprehensive flow cytometry panel for idiopathic subglottic stenosis (iSGS).Study DesignControlled ex vivo cohort study.SettingTertiary care academic hospital in a metropolitan area.MethodsFlow cytometry and single‐cell RNA sequencing were performed on 9 paired normal and scar tissue samples from iSGS patients. Flow cytometry was used to assess the presence of myeloid (CD11b, CD14, CD15, Siglec8), lymphoid (CD3, CD4, CD8, gamma delta [γδ], FOXP3), endothelial (CD31), fibroblast (CD90, SMA), and epithelial (CD326, CK5) markers.ResultsOn flow cytometry, iSGS scar is characterized by an increased presence of myeloid, lymphoid, endothelial, and fibroblast cell types, but a decreased presence of epithelial cells. In the myeloid lineage, iSGS scar samples demonstrated increased CD11b+ monocytes (P < .001), Siglec8+ eosinophils (P = .03), and CD14+ monocytes (P = .02). In the lymphoid lineage, iSGS scar demonstrated increased CD3+ T‐cells (P < .001), CD4+ helper T‐cells (P < .001), γδ+ T‐cells (P < .001), and FOXP3+ regulatory T‐cells (P = .002). iSGS scar exhibited specific increases in CD90+ (P = .04) and SMA+ (P < .001) fibroblasts but decreased CD326+ (E‐cadherin) epithelial cells (P = .01) relative to normal samples.ConclusionWe present a comprehensive flow cytometry panel for iSGS. This flow panel may serve as a common platform among airway scientists to elucidate the cellular mechanisms underpinning iSGS and other upper airway pathologies. Scar iSGS samples demonstrate a distinct cellular profile relative to normal iSGS specimens, exhibiting increased fibroblast, endothelial, and inflammatory cell types but decreased epithelium. 10.1002/ohn.754 http://onlinelibrary.wiley.com/termsAndConditions#vor
title A Comprehensive Flow Cytometry Panel for Analysis of Idiopathic Subglottic Stenosis
topic Otolaryngology–Head and Neck Surgery
url https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1002/ohn.754